[go: up one dir, main page]

TN2011000235A1 - Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus - Google Patents

Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus

Info

Publication number
TN2011000235A1
TN2011000235A1 TN2011000235A TN2011000235A TN2011000235A1 TN 2011000235 A1 TN2011000235 A1 TN 2011000235A1 TN 2011000235 A TN2011000235 A TN 2011000235A TN 2011000235 A TN2011000235 A TN 2011000235A TN 2011000235 A1 TN2011000235 A1 TN 2011000235A1
Authority
TN
Tunisia
Prior art keywords
active ingredients
granules
novel process
preparing pellets
preparing
Prior art date
Application number
TN2011000235A
Other languages
English (en)
Inventor
Pascal Suplie
Christophe Lebon
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2011000235(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of TN2011000235A1 publication Critical patent/TN2011000235A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Glanulating (AREA)
  • Fertilizers (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)

Abstract

La présente invention concerne un procédé de préparation d'un granulé d'au moins deux principes actifs, comprenant une étape d'application par poudrage desdits principes actifs sur un support particulaire solide, lesdits principes actifs n'étant pas des extraits de plantes.
TN2011000235A 2008-11-14 2011-05-12 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus TN2011000235A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
PCT/FR2009/052180 WO2010055268A1 (fr) 2008-11-14 2009-11-13 Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus

Publications (1)

Publication Number Publication Date
TN2011000235A1 true TN2011000235A1 (fr) 2012-12-17

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000235A TN2011000235A1 (fr) 2008-11-14 2011-05-12 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus

Country Status (25)

Country Link
US (1) US20110280945A1 (fr)
EP (1) EP2349226A1 (fr)
JP (1) JP5608681B2 (fr)
KR (1) KR101585705B1 (fr)
CN (1) CN102223879A (fr)
AR (1) AR074330A1 (fr)
AU (1) AU2009315449B2 (fr)
BR (1) BRPI0916019A2 (fr)
CA (1) CA2743753A1 (fr)
CL (1) CL2011001115A1 (fr)
CO (1) CO6382108A2 (fr)
CU (1) CU20110107A7 (fr)
EA (1) EA201100757A1 (fr)
FR (1) FR2938432B1 (fr)
IL (1) IL212850A0 (fr)
MA (1) MA32789B1 (fr)
MX (1) MX2011005072A (fr)
NZ (1) NZ592857A (fr)
PE (1) PE20110945A1 (fr)
SG (1) SG195651A1 (fr)
TN (1) TN2011000235A1 (fr)
TW (1) TWI522113B (fr)
UA (1) UA103781C2 (fr)
WO (1) WO2010055268A1 (fr)
ZA (1) ZA201103543B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers
KR20240157168A (ko) * 2023-04-24 2024-11-01 주식회사 케이티앤지 바인더를 사용하는 파우치 충진 물질의 제조 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
CN1164262C (zh) * 1999-05-17 2004-09-01 D.B.F.公司 含有植物物质的颗粒及其制备方法
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
EP2056792B1 (fr) * 2006-08-31 2023-06-07 Adare Pharmaceuticals, Inc. Systèmes d'administration de médicament comprenant des solutions solides de médicaments faiblement basiques
ES2403103T3 (es) * 2007-02-14 2013-05-14 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Agente dispersante para pigmento orgánico y su utilización
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
PE20110945A1 (es) 2012-02-01
AR074330A1 (es) 2011-01-05
TWI522113B (zh) 2016-02-21
NZ592857A (en) 2013-07-26
MA32789B1 (fr) 2011-11-01
WO2010055268A1 (fr) 2010-05-20
FR2938432B1 (fr) 2011-05-20
IL212850A0 (en) 2011-07-31
UA103781C2 (uk) 2013-11-25
EA201100757A1 (ru) 2011-12-30
US20110280945A1 (en) 2011-11-17
BRPI0916019A2 (pt) 2015-11-10
AU2009315449B2 (en) 2015-03-26
AU2009315449A1 (en) 2010-05-20
JP2012508786A (ja) 2012-04-12
MX2011005072A (es) 2011-10-03
SG195651A1 (en) 2013-12-30
JP5608681B2 (ja) 2014-10-15
KR101585705B1 (ko) 2016-01-15
CA2743753A1 (fr) 2010-05-20
CO6382108A2 (es) 2012-02-15
CL2011001115A1 (es) 2011-11-11
TW201029667A (en) 2010-08-16
CN102223879A (zh) 2011-10-19
KR20110095888A (ko) 2011-08-25
EP2349226A1 (fr) 2011-08-03
FR2938432A1 (fr) 2010-05-21
ZA201103543B (en) 2012-01-25
CU20110107A7 (es) 2012-01-31

Similar Documents

Publication Publication Date Title
TN2011000235A1 (fr) Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
MX2020012660A (es) Compuestos de cianuro de doble metal altamente activos.
WO2013091775A3 (fr) Utilisation de dérivés du cyclohéxanol comme principes actifs antimicrobiens
MX2008011107A (es) Catalizadores de metal de transicion fluorados y formacion de los mismos.
EA201170742A1 (ru) Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламинов и их применения
PH12013500954A1 (en) Drug derivatives
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
FR3041351B1 (fr) Procede de preparation d'une poudre d'algues a teneur reduite en proteines et composition bioplastique formulee a partir d'une telle poudre
MA33679B1 (fr) Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole
FR2987046B1 (fr) Procede d'hydroxylation de composes aromatiques, catalyseur d'hydroxylation et son procede de preparation
MA35674B1 (fr) Derives de chromone, leur procede de preparation et leurs applications therapeutiques
ZA202207729B (en) Solid state form of pyroxasulfone
WO2012070069A8 (fr) Procédé de préparation d'albendazole
MA28449B1 (fr) Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
MX2009008616A (es) Antagonistas del receptor de dopamina 2 de rapida disociacion.
FR2938777B1 (fr) Catalyseur en coquille, procede de preparation et utilisation de ce catalyseur.
TW200732321A (en) Fast dissociating dopamine 2 receptor antagonists
FR3064262B1 (fr) Procede de synthese de la zeolithe izm-2 en presence d'un structurant dibromure de 1,6-bis(methylpiperidinium)hexane
WO2013080140A3 (fr) Compositions d'écran solaire contenant un nouveau système de conservateur
WO2018193090A3 (fr) Procédé de préparation d'hémitartrate d'eliglustat et d'intermédiaires de celui-ci
WO2010026467A3 (fr) Forme pharmaceutique à libération prolongée de principe actif hautement soluble
MA41174B1 (fr) Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta
MA38250A1 (fr) Nouveau dérivés d'hydantoïne pour leurs utilisations dans le traitement de maladies, comme l'osteoporose et la thrombocytopenie
WO2009029540A3 (fr) Procédés, systèmes de production chimique et compositions catalytiques
WO2006102722A8 (fr) Procede de production de $g(g)-glutamylcysteine